| Latest Orthovita News Headlines |
| Date | Time | Source | |
| 06/27/2008 | 9:20AM | PRNUS | BeaconEquity.com Issues TraderNotes on Active Stocks: TAOL, BBX, FMD, VLNC, VRNM, VITA, BLDP, CTX
DALLAS, June 27 /PRNewswire/ -- BeaconEquity.com announces the availability of TraderNotes on stocks that are making news today.
Investors can view all of the daily trading notes for free by visiting:
http://www.beaconequity.com/m
Today's TraderNotes include: Tao Minerals Ltd. (OTC:TAOL) (BULLETIN BOARD: TAOL... More...>> |
| 01/26/2007 | 7:30AM | PRNUS | Kensey Nash Reports Second Quarter EPS Growth of 63% on 27% Growth in Revenue -Biomaterials Sales Increased 29% and Endovascular Sales Reached Record Levels of $1.2 million-
EXTON, Pa., Jan. 26 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (NASDAQ:KNSY) today reported total revenue of $17.3 million for its quarter ending December 31, 2006, up 27% from the $13.6 million reported in the second... More...>> |
| 10/19/2006 | 7:00AM | PRNUS | Kensey Nash Reports 28% Growth in Revenue for First Fiscal Quarter 2007 - Revenue Growth Led By 41% Increase in Net Sales; EPS Increased 57% over Prior Year Pro Forma Results -
EXTON, Pa., Oct. 19 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (NASDAQ:KNSY) today reported results for its first quarter of fiscal year 2007, which included total revenue of $16.3 million, up 28% from the... More...>> |
| 08/21/2006 | 7:30AM | PRNUS | Kensey Nash Reports Fourth Quarter and Fiscal Year 2006 Results Including Record Fourth Quarter Sales and Revenues Earnings per Share at High End of Previously Announced Estimates
EXTON, Pa., Aug. 21 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (NASDAQ:KNSY) today reported results for its fourth quarter of fiscal year 2006, which were at the high end of previously announced estimates.
Fourth Quarter Results. Fourth quarter... More...>> |
| 04/24/2006 | 7:30AM | PRNUS | Kensey Nash Reports Third Quarter Fiscal Year 2006 Results at High End of Previously Announced Estimates
EXTON, Pa., April 24 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (NASDAQ:KNSY) today reported results for its third quarter of fiscal year 2006, which were at the high end of previously announced estimates.
Third Quarter Results. Third quarter pro forma diluted earnings of $0.21 per share, excluding facility... More...>> |
| 03/20/2006 | 7:00AM | PRNUS | Orthovita and Aastrom Biosciences Announce Collaboration Agreement for Orthopedic Products -- Alliance to Combine Aastrom Tissue Repair Cells and Orthovita VITOSS(R) for Bone Tissue Regeneration --
ANN ARBOR, Mich., and MALVERN, Pa., March 20 /PRNewswire-FirstCall/ -- Aastrom Biosciences, Inc. (NASDAQ:ASTM) and Orthovita, Inc. (NASDAQ:VITA) jointly announced today they have signed an agreement to develop... More...>> |
| 10/25/2005 | 6:36PM | PRNUS | Kensey Nash Reports First Quarter Fiscal Year 2006 Results
EXTON, Pa., Oct. 25 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (NASDAQ:KNSY) today reported results for its first quarter of fiscal year 2006 and updated the Company's progress on development and marketing of its Endovascular product lines.
First Quarter Results. Total revenues for the first quarter were $12.7... More...>> |
| 08/17/2005 | 6:01PM | PRNUS | Kensey Nash Reports Fourth Quarter and Fiscal Year 2005 Results - Fourth Quarter Pro-Forma EPS of $0.32 and as Reported EPS of $
EXTON, Pa., Aug. 17 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (NASDAQ:KNSY) today reported results for its fourth quarter and fiscal year ended June 30, 2005.
Total revenues were $16.3 million for the quarter and $61.4 million for the fiscal year, in line with the company's latest guidance of $61.0 to $62.0... More...>> |
| 04/20/2005 | 4:03PM | PRNUS | Kensey Nash Reports Third Quarter Results, Announces Earnings of $0.26 Per Share and Revenues of $14.8 Million Kensey Nash Reports Third Quarter Results, Announces Earnings of
$0.26 Per Share and Revenues of $14.8 Million
EXTON, Pa., April 20 /PRNewswire-FirstCall/ -- Kensey Nash Corporation
(NASDAQ:KNSY) today announced earnings of $0.26 per share and revenues of $14.8
million for its third fiscal quarter ended March 31, 2005... More...>> |
| 03/03/2005 | 7:00AM | PRNUS | Kensey Nash Corporation and Orthovita, Inc. Announce New Agreements to Jointly Develop Soft Tissue Repair Products and Extend Co Kensey Nash Corporation and Orthovita, Inc. Announce New
Agreements to Jointly Develop Soft Tissue Repair Products and Extend
Co-Development Relationship
EXTON, Pa. and MALVERN, Pa., March 3 /PRNewswire-FirstCall/ -- Kensey Nash
Corporation (NASDAQ:KNSY) and Orthovita, Inc. (NASDAQ:VITA) today jointly
announced they... More...>> |
| 01/19/2005 | 5:18PM | PRNUS | Kensey Nash Reports Better Than Expected Second Quarter EPS of $0.27, an Increase of 18% Over Prior Year Period Kensey Nash Reports Better Than Expected Second Quarter EPS of
$0.27, an Increase of 18% Over Prior Year Period
-Net Sales Increases 27% Over Prior Year Period-
EXTON, Pa., Jan. 19 /PRNewswire-FirstCall/ -- Kensey Nash Corporation
(NASDAQ:KNSY) today reported earnings per share of $0.27 for its second fiscal
quarter... More...>> |
| 01/11/2005 | 9:00AM | PRNUS | Angiotech and Orthovita announce commercial launch of Vitagel(TM) Angiotech and Orthovita announce commercial launch of Vitagel(TM)
VANCOUVER, BC and MALVERN, PA, Jan. 11 /PRNewswire-FirstCall/ -- Angiotech
Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP) and Orthovita, Inc.
(NASDAQ:VITA) today announced that the companies have begun the official
commercial launch of Vitagel(TM... More...>> |
| 10/20/2004 | 4:50PM | PRNUS | Kensey Nash Announces EPS of $0.26 for First Quarter, Exceeding Previous Guidance of $0.23 to $0.24 Kensey Nash Announces EPS of $0.26 for First Quarter, Exceeding
Previous Guidance of $0.23 to $0.24
- Also Reports 38% Increase in Net Sales for Its First Fiscal Quarter -
EXTON, Pa., Oct. 20 /PRNewswire-FirstCall/ -- Kensey Nash Corporation
(NASDAQ:KNSY) today announced earnings of $0.26 per share for its first fiscal
quarter... More...>> |
| 08/17/2004 | 6:23PM | PRNUS | Kensey Nash Reports Record Q4 E.P.S. of $0.34 - Fourth Quarter Net Sales Increased 40% Over Prior Year - - Plans TriActiv(R) U.S Kensey Nash Reports Record Q4 E.P.S. of $0.34 - Fourth Quarter
Net Sales Increased 40% Over Prior Year - - Plans TriActiv(R) U.S. Distribution
With Direct Sales Force -
EXTON, Pa., Aug. 17 /PRNewswire-FirstCall/ -- Kensey Nash Corporation
(NASDAQ:KNSY) today announced record revenue, net sales and earnings per share
for... More...>> |